Bimekizumab versus Adalimumab in Plaque Psoriasis. Reply
- PMID: 34525294
- DOI: 10.1056/NEJMc2113092
Bimekizumab versus Adalimumab in Plaque Psoriasis. Reply
Comment on
-
Bimekizumab versus Adalimumab in Plaque Psoriasis.N Engl J Med. 2021 Sep 16;385(12):1149-1150. doi: 10.1056/NEJMc2113092. N Engl J Med. 2021. PMID: 34525293 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical